The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Travel, Accommodations, Expenses - Janssen
 
Stock and Other Ownership Interests - Pfizer
Honoraria - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Hoffman-La Roche Ipsen; Janssen; Merck; Novartis; Pfizer
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; Hoffman-La Roche Ipsen; Janssen; Merck; Novartis; Pfizer
Research Funding - AstraZeneca; Bayer; Janssen; Merck
Travel, Accommodations, Expenses - Janssen; Pfizer
Practice patterns and predictors of treatment intensification in patients with metastatic castration-sensitive prostate cancer.
 
Geoffrey T. Gotto
Honoraria - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; EMD Serono; Ferring; Janssen; McKesson; Merck; Pfizer; Sanofi; Tolmar
Research Funding - Janssen
Expert Testimony - Janssen
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen
 
Steven M. Yip
No Relationships to Disclose
 
Bobby Shayegan
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen Oncology; Knight Pharmaceuticals; Novartis Canada Pharmaceuticals Inc; Novartis Canada Pharmaceuticals Inc; Tersera; Tolmar
 
Dylan E. O'Sullivan
No Relationships to Disclose
 
Christopher J.D. Wallis
Honoraria - Bayer; EMD Serono; Haymarket Medical Education; Knight Therapeutics; Tersera; Tolmar
Consulting or Advisory Role - Janssen Oncology; Precision Point Specialty; Sesen Bio
Research Funding - Knight Therapeutics
Travel, Accommodations, Expenses - Tolmar
 
Naveen S. Basappa
Stock and Other Ownership Interests - illumiSonics
Honoraria - Astellas Pharma; Eisai; Ipsen; Janssen; Merck; Pfizer
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Ipsen; Janssen; Merck; Pfizer; Roche Canada
Travel, Accommodations, Expenses - Eisai; Janssen
 
Ilias Cagiannos
Honoraria - Abbvie; Astellas Pharma; Ferring; Knight Pharmaceuticals
Consulting or Advisory Role - Abbvie; Astellas Pharma; Janssen
 
Robert James Hamilton
Honoraria - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen
Travel, Accommodations, Expenses - Janssen; Tolmar
 
Cristiano Ferrario
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Knight Pharmaceuticals; Merck; Novartis; Pfizer; Roche Canada
Consulting or Advisory Role - AstraZeneca; Bayer; Merck; Novartis; Roche; Seagen
Speakers' Bureau - AstraZeneca; Knight Therapeutics; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer; Bicycle Therapeutics (Inst); Immunomedics (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Zymeworks (Inst)
Expert Testimony - Seattle Genetics/Astellas
Travel, Accommodations, Expenses - Novartis; Roche
 
Ricardo Fernandes
Honoraria - Bayer; Bayer; Ipsen; Merck; Pfizer
Consulting or Advisory Role - Bayer; Bayer; Janssen; Janssen; Janssen; Janssen; Janssen; Merck; Novartis Canada Pharmaceuticals Inc; Pan-Canadian Oncology Drug Review (pCODR); Pfizer
Travel, Accommodations, Expenses - Janssen
 
Brita Danielson
Honoraria - Amgen; Astellas Pharma; Bayer; Ferring; Janssen; Tolmar
Consulting or Advisory Role - AAA/Endocyte/Novartis; Janssen
Speakers' Bureau - Janssen
Travel, Accommodations, Expenses - Ferring; Janssen; Tolmar
 
Fred Saad
Honoraria - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; BMS; Janssen Oncology; Knight Therapeutics; Merck; Myovant Sciences; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Advanced Accelerator Applications; Astellas Pharma; AstraZeneca/MedImmune; Bayer; Janssen Oncology; Knight Therapeutics; Myovant Sciences; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Sanofi (Inst)
 
Sebastien J. Hotte
Honoraria - Astellas Scientific and Medical Affairs Inc; Bayer; Eisai; Ipsen; Janssen Oncology; Merck
Consulting or Advisory Role - Advanced Accelerator Applications; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Merck; Pfizer; Seagen
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Janssen Oncology (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Seagen (Inst); SignalChem (Inst)
Travel, Accommodations, Expenses - Eisai
 
Darren R. Brenner
Employment - Cytel
 
Winson Y. Cheung
No Relationships to Disclose
 
Devon J. Boyne
Employment - Cytel
Research Funding - Oncology Outcomes
 
Katherine Chan
Employment - Janssen
 
Brendan Osborne
No Relationships to Disclose
 
Anousheh Zardan
Employment - Janssen
 
Shawn Malone
Honoraria - Abbvie; Amgen; Astellas Pharma; AstraZeneca; Bayer; Janssen; Knight Pharmaceuticals
Travel, Accommodations, Expenses - Sanofi; Tersera